Advertisement

OZONE pp 35-74 | Cite as

The Actual Six Therapeutic Modalities

  • Velio Bocci
Chapter

Abstract

Parenteral administration of ozone may represent the key to solve some medical problems when orthodox medicine has failed to do so. To the old procedures: major and minor ozonated autohaemotherapy (AHT) and rectal insufflation, our work has permitted the addition of three new options and all of them will be critically examined in this chapter.

Keywords

Ozone Concentration Fresh Freeze Plasma Venous Access Total Antioxidant Status Ozone Generator 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Ahlman, H., and Nilsson, O., 2001, The gut as the largest endocrine organ in the body, Ann. Oncol. 12:S63–S68.PubMedCrossRefGoogle Scholar
  2. Ardizzone, S., and Bianchi Porro, G., 2002, Inflammatory bowel disease: new insights into pathogenesis and treatment, J. Intern. Med. 252:475–496.PubMedCrossRefGoogle Scholar
  3. Aubourg, P., 1936, Colibacillose aigue, colibacillose cronique: ameliorations cliniques notables par un traitement d’ozone, Bull. Med. Paris 140:644–654.Google Scholar
  4. Babior, B. M., 1978, Oxygen-dependent microbial killing by phagocytes (1st and 2nd part), N. Engl. J. Med. 298:659–668.PubMedCrossRefGoogle Scholar
  5. Badwey, J. A., and Karnovsky, M. L., 1980, Active oxygen species and the functions of phagocytic leukocytes, Annu. Rev. Biochem. 49:695–726.PubMedCrossRefGoogle Scholar
  6. Barber, E., Menéndez, S., León, O. S., Barber, M. O., Merino, N., Calunga, J. L., Cruz, E., and Bocci, V., 1999, Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischaemia, Mediators Inflamm. 8:37–41.PubMedCrossRefGoogle Scholar
  7. Bergqvist, D., 1999, Salvage of critically ischaemic limbs, Lancet 354:1920–1921.PubMedCrossRefGoogle Scholar
  8. Bocci, V., 1981b, Pharmacokinetic studies of interferons, Pharmacol. Ther. 13(3):421–440.PubMedCrossRefGoogle Scholar
  9. Bocci, V., 1981c, Production and role of interferon in physiological conditions, Biol. Rev. 56: 49–85.PubMedCrossRefGoogle Scholar
  10. Bocci, V., 1988a, Roles of interferon produced in physiological conditions. A speculative review, Immunology 64:1–9.PubMedGoogle Scholar
  11. Bocci, V., 1988c, Roles of interferon produced in physiological conditions. A speculative review, Immunology 64:1–9.PubMedGoogle Scholar
  12. Bocci, V., 1992c, The neglected organ: bacterial flora has a crucial immunostimulatory role, Perspect. Biol. Med. 35:251–260.PubMedGoogle Scholar
  13. Bocci, V., 1996b, Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today, J. Biol. Regul. Homeost. Agents 10:31–53.PubMedGoogle Scholar
  14. Bocci, V., 1996c, Ozone: a mixed blessing. New mechanisms of the action of ozone on blood cells make ozonated major autohaemotherapy (MAH) a rational approach, Forsch. Komplementärmed. 3:25–33.CrossRefGoogle Scholar
  15. Bocci, V., 2002, Oxygen-ozone therapy, a critical evaluation, Kluwer Academic Publischer, Dordrecht.Google Scholar
  16. Bocci, V., 2006a, Scientific and medical aspects of ozone therapy, state of the art, Arch. Med. Res. 37:425–435.PubMedCrossRefGoogle Scholar
  17. Bocci, V., 2007 Può l’Ossigeno-Ozonoterapia migliorare la prognosi della bronco-pneumopatia cronica ostruttiva? Giorn. Ital. Mal. Tor. 61:434–446.Google Scholar
  18. Bocci, V., and Di Paolo, N., 2004, Oxygenation-ozonization of blood during extracorporeal circulation (EBOO). Part III: a new medical approach, Ozone Sci. Eng. 26:195–205.CrossRefGoogle Scholar
  19. Bocci, V., Borrelli, E., Corradeschi, F., and Valacchi, G., 2000, Systemic effects after colorectal insufflation of oxygen-ozone in rabbits, Int. J. Med. Biol. Environ. 28:109–113.Google Scholar
  20. Bocci, V., Borrelli, E., Valacchi, G., and Luzzi, E., 1999a, Quasi-total-body exposure to an oxygen-ozone mixture in a sauna cabin, Eur. J. Appl. Physiol. Occup. Physiol. 80:549–554.PubMedCrossRefGoogle Scholar
  21. Bocci, V., Borrelli, E., Travagli, V., and Zanardi, I., 2008, The term “liquid polyatomic oxygen” requires a correction but chemo and radiotherapy combined with ozone therapy may help cancer patients, Int. J. Ozone Ther. 7:63–65.Google Scholar
  22. Bocci, V., Di Paolo, N., Borrelli, E., Larini, A., and Cappelletti, F., 2001b, Ozonation of blood during extracorporeal circulation II. Comparative analysis of several oxygenators-ozonators and selection of one type, Int. J. Artif. Organs 24:890–897.PubMedGoogle Scholar
  23. Bocci, V., Di Paolo, N., Garosi, G., Aldinucci, C., Borrelli, E., Valacchi, G., Cappelli, F., Guerri, L., Gavioli, G., Corradeschi, F., Rossi, R., Giannerini, F., and Di Simplicio, P., 1999b, Ozonation of blood during extracorporeal circulation. I. Rationale, methodology and preliminary studies, Int. J. Artif. Organs 22:645–651.PubMedGoogle Scholar
  24. Bocci, V., Larini, A., and Micheli, V., 2005, Restoration of normoxia by ozone therapy may control neoplastic growth: a review and a working hypothesis, J. Altern. Complement. Med. 11:257–265.PubMedCrossRefGoogle Scholar
  25. Bocci, V., Luzzi, E., Corradeschi, F., Paulesu, L., and Di Stefano, A., 1993a, Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines, Lymphokine Cytokine Res. 12:121–126.PubMedGoogle Scholar
  26. Bocci, V., Luzzi, E., Corradeschi, F., Paulesu, L., Rossi, R., Cardaioli, E., and Di Simplicio, P., 1993b, Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes, J. Biol. Regul. Homeost. Agents 7:133–138.PubMedGoogle Scholar
  27. Bocci, V., Travagli, V., and Zanardi, I., 2009b, The failure of HIV vaccines: a new autovaccine may overcome some problems, Med. Hypothesis 72:662–664.CrossRefGoogle Scholar
  28. Bocci, V., Valacchi, G., Corradeschi, F., Aldinucci, C., Silvestri, S., Paccagnini, E., and Gerli, R., 1998a, Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone, J. Biol. Regul. Homeost. Agents 12:67–75.PubMedGoogle Scholar
  29. Bocci, V., Valacchi, G., Corradeschi, F., and Fanetti, G., 1998b, Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production, Mediators Inflamm. 7:313–317.PubMedCrossRefGoogle Scholar
  30. Borrego, A., Zamora, Z. B., Gonzalez, R., Romay, C., Menendez, S., Hernandez, F., Montero, T., and Rojas, E., 2004, Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats, Mediators Inflamm. 13:13–19.PubMedCrossRefGoogle Scholar
  31. Boxer, L. A., and Smolen, J. E., 1988, Neutrophil granule constituents and their release in health and disease, Hematol. Oncol. Clin. N. Am. 2:101–134.Google Scholar
  32. Burgassi, S., Zanardi, I., Travagli, V., Montomoli, E., and Bocci, V., 2009, How much ozone bactericidal activity is compromised by plasma components? J. Appl. Microbiol. 106:1715–1721.PubMedCrossRefGoogle Scholar
  33. Callahan, J. T., Collecutt, M. F., Lightbody, J. R., and Faragher, B. S., 1982, Alteration of human red blood cells stored in plastic packs, Transfusion 22:154–157.PubMedCrossRefGoogle Scholar
  34. Carpendale, M. T., Freeberg, J., and McLeod Griffiss, J., 1993, Does Ozone alleviate AIDS diarrhea? J. Clin. Gastroenterol. 17:142–145.PubMedCrossRefGoogle Scholar
  35. Castagnola, E., Molinari, A. C., Fratino, G., and Viscoli, C., 2003, Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary, Br. J. Haematol. 121:233–239.PubMedCrossRefGoogle Scholar
  36. Cooke, E. D., Pockley, A. G., Tucker, A. T., Kirby, J. D. T., and Bolton, A. E., 1997, Treatment of severe Raynaud’s syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy, Int. Angiol. 16:250–254.PubMedGoogle Scholar
  37. D’Ambrosio, C. M., 2002a, Trattamento delle malattie infiammatorie croniche dell’intestino mediante ossigeno-ozonoterapia, Riv. Ital. Ossigeno Ozonoterapia 1:155–158.Google Scholar
  38. D’Ambrosio, C. M., 2002b, Terapia delle IBD mediante ozonoterapia per via rettale, Riv. Ital. Ossigeno Ozonoterapia 1:159–163.Google Scholar
  39. Dernek, S., Tunerir, B., Sevin, B., Aslan, R., Uyguc, O., and Kural, T., 1999, The effects of methylprednisolone on complement, immunoglobulins and pulmonary neutrophil sequestration during cardiopulmonary bypass, Cardiovasc. Surg. 7:414–418.PubMedCrossRefGoogle Scholar
  40. Di Paolo, N., Bocci, V., Cappelletti, F., Petrini, G., and Gaggiotti, E., 2002, Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO), Int. J. Artif. Organs 25:1194–1198.PubMedGoogle Scholar
  41. Di Paolo, N., Bocci, V., Garosi, G., Borrelli, E., Bravi, A., Bruci, A., Aldinucci, C., and Capotondo, L., 2000, Extracorporeal blood oxigenation and ozonation (EBOO) in man. Preliminary report, Int. J. Artif. Organs 23:131–141.PubMedGoogle Scholar
  42. Di Paolo, N., Bocci, V., Salvo, D. P. et al., 2005, Extracorporeal blood oxygenation and ozonation (EBOO). A controlled trial in patients with peripheral artery disease, Int. J. Artif. Organs 28:1039–1050.PubMedGoogle Scholar
  43. Didier, C., Pouget, J. P., Cadet, J., Favier, A., Beani, J. C., and Richard, M. J., 2001, Modulation of exogenous and endogenous levels of thioredoxin in human skin fibroblasts prevents DNA damaging effect of ultraviolet A radiation, Free Radic. Biol. Med. 30:537–546.PubMedCrossRefGoogle Scholar
  44. Edmunds, L. H., Jr., 1998, Inflammatory response to cardiopulmonary bypass, Ann. Thorac. Surg. 66:S12–S16.PubMedCrossRefGoogle Scholar
  45. Eliakim, R., Karmeli, F., Rachmilewitz, D., Cohen, P., and Zimran, A., 2001, Ozone enema: a model of microscopic colitis in rats, Dig. Dis. Sci. 46:2515–2520.PubMedCrossRefGoogle Scholar
  46. Farr, C. H., 1993, Protocol for the intravenous administration of hydrogen peroxide, International Bio-Oxidative Medicine Foundation, Oklahoma City, OK, pp. 29–31.Google Scholar
  47. Fiocchi, C., 1998, Inflammatory bowel disease: etiology and pathogenesis, Gastroenterology 115:182–205.PubMedCrossRefGoogle Scholar
  48. Fiocchi, C., 1999, From immune activation to gut tissue injury: the pieces of the puzzle are coming together, Gastroenterology 117:1238–1241.PubMedCrossRefGoogle Scholar
  49. Foksinski, M., Bialkowski, K., Skiba, M., Ponikowska, I., Szmurlo, W., and Olinski, R., 1999, Evaluation of 8-oxodeoxyguanosine, typical oxidative DNA damage, in lymphocytes of ozone-treated arteriosclerotic patients, Mutat. Res. 438:23–27.PubMedCrossRefGoogle Scholar
  50. Fuchs, J., and Kern, H., 1998, Modulation of UV-light-induced skin inflammation by D-alpha-tocopherol and L-ascorbic acid: a clinical study using solar simulated radiation, Free Radic. Biol. Med. 25:1006–1012.PubMedCrossRefGoogle Scholar
  51. Gabriel, C., Blauhut, B., Greul, R., Schneewels, B., and Roggendorf, M., 1996, Transmission of hepatitis C by ozone enrichment of autologous blood, Lancet 347:541.PubMedCrossRefGoogle Scholar
  52. Garber, G. E., Cameron, D. W., Hawley-Foss, N., Greenway, D., and Shannon, M. E., 1991, The use of ozone-treated blood in the therapy of HIV infection and immune disease: a pilot study of safety and efficacy, AIDS 5:981–984.PubMedCrossRefGoogle Scholar
  53. Gonzalez, R., Borrego, A., Zamora, Z., Romay, C., Hernandez, F., Menendez, S., Montero, T., and Rojas, A., 2004, Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats, Mediators Inflamm. 13:13–20.PubMedCrossRefGoogle Scholar
  54. Haas, A. F., Wong, J. W., Iwahashi, C. K., Halliwell, B., Cross, C. E., and Davis, P. A., 1998, Redox regulation of wound healing? NF-kappaB activation in cultured human keratinocytes upon wounding and the effect of low energy HeNe irradiation, Free Radic. Biol. Med. 25:998–1005.PubMedCrossRefGoogle Scholar
  55. Hanauer, S. B., and Dassopoulos, T., 2001, Evolving treatment strategies for inflammatory bowel disease, Annu. Rev. Med. 52:299–318.PubMedCrossRefGoogle Scholar
  56. Hannuksela, M. L., and Ellahham, S., 2001, Benefits and risks of sauna bathing, Am. J. Med. 110:118–126.PubMedCrossRefGoogle Scholar
  57. Hooper, L. V., and Gordon, J. I., 2001, Commensal host-bacterial relationships in the gut, Science 292:1115–1118.PubMedCrossRefGoogle Scholar
  58. Ikonomidis, S., Tsaousis, P., Fyntanis, A. et al., 2005, New data regarding the use of oxidative stress (ozone therapy) in the former Soviet Union countries, Riv. Ital. Ossigeno Ozonoterapia 4:40–43.Google Scholar
  59. Iuliano, L., Colavita, A. R., Leo, R., Praticò, D., and Violi, F., 1997, Oxygen free radicals and platelet activation, Free Radic. Biol. Med. 22:999–1006.PubMedCrossRefGoogle Scholar
  60. Kelly, F. J., Mudway, I., Krishna, M. T., and Holgate, S. T., 1995, The free radical basis of air pollution: focus on ozone, Resp. Med. 89:647–656.CrossRefGoogle Scholar
  61. Knoch, H.-G., Roschke, W., and Klug, W., 1987, Ozone/oxygen therapy in proctology, OzoNachrichten 6:51–70.Google Scholar
  62. Konrad, H., 2001, Ozone therapy for post-herpetic neuralgia. A retrospective study of 55 cases, in Proceedings of the 15th Ozone World Congress, London, UK, 11th–15th September 2001, Medical Therapy Conference (IOA 2001, Ed.), Speedprint MacMedia Ltd, Ealing, London, UK, pp. 85–88.Google Scholar
  63. Labow, R. S., Tocchi, M., and Rock, G., 1986, Contamination of platelet storage bags by phthalate esters, Toxicol. Environ. Health 19:591–598.CrossRefGoogle Scholar
  64. Lawrence, W. H., 1978, Phthalate esters: the question of safety, Clin. Toxicol. 13:89.PubMedCrossRefGoogle Scholar
  65. León, O. S., Menéndez, S., Merino, N., Castillo, R., Sam, S., Pérez, L., Cruz, E., and Bocci, V., 1998, Ozone oxidative preconditioning: a protection against cellular damage by free radicals, Mediators Inflamm. 7:289–294.PubMedCrossRefGoogle Scholar
  66. Levine, M., Espey, M. G., and Chen, Q., 2009, Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment, Free Radic. Biol. Med. 47:27–29.PubMedCrossRefGoogle Scholar
  67. Lewis, L. M., Flechtner, T. W., Kerkay, J., Pearson, K. H., Chen, W. T., Popowniak, K. L., and Nakamoto, S., 1977, Determination of plasticizer levels in serum of hemodialysis patients, Trans. Am. Soc. Artif. Intern. Organs 23:566–572.PubMedCrossRefGoogle Scholar
  68. Lippman, M., 1989, Health effects of ozone, a critical review, J. Am. Air Pollut. Control Assoc. 39:672–695.Google Scholar
  69. Los, M., Dröge, W., Stricker, K., Baeuerle, P. A., and Schulze-Osthoff, K., 1995, Hydrogen peroxide as a potent activator of T lymphocyte functions, Eur. J. Immunol. 25:159–165.PubMedCrossRefGoogle Scholar
  70. Love, I. N., 1888, Peroxide of hydrogen as a remedial agent, JAMA 262–265.Google Scholar
  71. Masschelein, W. J., 1996, Iodometric method for the determination of ozone in a process gas, in Ozon-Handbuch. Grundlagen. Prävention. Therapie (E. G. Beck, and R. Viebahn-Hänsler, Eds.), Ecomed, Landsberg, pp. 1–3.Google Scholar
  72. Meewes, C., Brenneisen, P., Wenk, J., Kuhr, L., Ma, W., Alikoski, J., Poswig, A., Krieg, T., and Scharffetter-Kochanek, K., 2001, Adaptive antioxidant response protects dermal fibroblasts from UVA- induced phototoxicity, Free Radic. Biol. Med. 30:238–247.PubMedCrossRefGoogle Scholar
  73. Morena, M., Cristol, J. P., and Canaud, B., 2000, Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance, Blood Purif. 18:191–199.PubMedCrossRefGoogle Scholar
  74. Mouitys-Mickalad, A., Deby, C., Deby-Dupont, G., and Lamy, M., 1998, An electron spin resonance (ESR) study on the mechanism of ascorbyl radical production by metal-binding proteins, BioMetals 11:81–88.CrossRefGoogle Scholar
  75. Nathan, C. F., and Cohn, Z. A., 1981, Antitumor effects of hydrogen peroxide in vivo, J. Exp. Med. 154:1539–1553.PubMedCrossRefGoogle Scholar
  76. Nicolaides, N., 1974, Skin lipids:their biochemical uniqueness, Science 186:19–26.PubMedCrossRefGoogle Scholar
  77. O’Farrelly, C., and Crispe, I. N., 1999, Prometheus through the looking glass: reflections on the hepatic immune system, Immunol. Today 20:394–398.PubMedCrossRefGoogle Scholar
  78. Okabe, N., 2001, The pathogenesis of Crohn’s disease, Digestion 63(Suppl 1):52–59.PubMedCrossRefGoogle Scholar
  79. Olwin, J. H., Ratajczak, H. V., and House, R. V., 1997, Successful treatment of herpetic infections by autohemotherapy, J. Altern. Complement. Med. 3:155–158.PubMedCrossRefGoogle Scholar
  80. Peralta, C., Leon, O. S., Xaus, C., Prats, N., Jalil, E. C., Planell, E. S., Puig-Parellada, P., Gelpi, E., and Rosello-Catafau, J., 1999, Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance, Free Radic. Res. 31:191–196.PubMedCrossRefGoogle Scholar
  81. Peralta, C., Xaus, C., Bartrons, R., Leon, O. S., Gelpi, E., and Rosello-Catafau, J., 2000, Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion, Free Radic. Res. 33:595–605.PubMedCrossRefGoogle Scholar
  82. Perdue, M. H., 1999, Mucosal immunity and inflammation III. The mucosal antigen barrier: cross talk with mucosal cytokines, Am. J. Physiol. 277:G1–G5.PubMedGoogle Scholar
  83. Podda, M., Traber, M. G., Weber, C., Yan, L.-J., and Packer, L., 1998, UV-irradiation depletes antioxidants and causes oxidative damage in a model of human skin, Free Radic. Biol. Med. 24:55–65.PubMedCrossRefGoogle Scholar
  84. Pryor, W. A., 1992, How far does ozone penetrate into the pulmonary air/tissue boundary before it reacts? Free Radic. Biol. Med. 12:83–88.PubMedCrossRefGoogle Scholar
  85. Pryor, W. A., Squadrito, G. L., and Friedman, M., 1995, The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products, Free Radic. Biol. Med. 19:935–941.PubMedCrossRefGoogle Scholar
  86. Renaud, B., and Brun-Buisson, C., 2001, Outcomes of primary and catheter-related bacteremia. A cohort and case- control study in critically ill patients, Am. J. Respir. Crit. Care Med. 163:1584–1590.PubMedGoogle Scholar
  87. Saliou, C., Kitazawa, M., McLaughlin, L., Yang, J. P., Lodge, J. K., Tetsuka, T., Iwasaki, K., Cillard, J., Okamoto, T., and Packer, L., 1999, Antioxidants modulate acute solar ultraviolet radiation-induced NF- kappa-B activation in a human keratinocyte cell line, Free Radic. Biol. Med. 26:174–183.PubMedCrossRefGoogle Scholar
  88. Sasaki, H., Wakutani, T., Oda, S., and Yamasaki, Y., 1967, Application of hydrogen peroxide infusion to maxillary cancer, Yonago Acta Med. 11:141–149.PubMedGoogle Scholar
  89. Schreiber, S., Heinig, T., Thiele, H. G., and Raedler, A., 1995, Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease, Gastroenterology 108:1434–1444.PubMedCrossRefGoogle Scholar
  90. Schulz, S., 1986, The role of ozone/oxygen in clindamycin-associated enterocolitis in the Djungarian hamster (Phodopus sungorus sungorus), Lab. Anim. 20:41–48.PubMedCrossRefGoogle Scholar
  91. Shanahan, F., 2002, Crohn’s disease, Lancet 359:62–69.PubMedCrossRefGoogle Scholar
  92. Stiller, B., Sonntag, J., Dahnert, I., Alexi-Meskishvili, V., Hetzer, R., Fischer, T., and Lange, P. E., 2001, Capillary leak syndrome in children who undergo cardiopulmonary bypass: clinical outcome in comparison with complement activation and C1 inhibitor, Intensive Care Med. 27:193–200.PubMedCrossRefGoogle Scholar
  93. Symons, M. C., Rusakiewicz, S., Rees, R. C., and Ahmad, S. I., 2001, Hydrogen peroxide: a potent cytotoxic agent effective in causing cellular damage and used in the possible treatment for certain tumours, Med. Hypotheses 57:56–58.PubMedCrossRefGoogle Scholar
  94. Tamura, Y., Peng, P., Liu, K., Daou, M., and Srivastava, P. K., 1997, Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations, Science 278:117–120.PubMedCrossRefGoogle Scholar
  95. Taylor, R. S., Belli, A. M., and Jacob, S., 1999, Distal venous arterialisation for salvage of critically ischaemic inoperable limbs, Lancet 354:1962–1965.PubMedCrossRefGoogle Scholar
  96. Thiele, J. J., Traber, M. G., Tsang, K., Cross, C. E., and Packer, L., 1997a, In vivo exposure to ozone depletes vitamins C and E and induces lipid peroxidation in epidermal layers of murine skin, Free Radic. Biol. Med. 23:385–391.PubMedCrossRefGoogle Scholar
  97. Thiele, J. J., Traber, M. T., Podda, M., Tsang, K., Cross, C. E., and Packer, L., 1997b, Ozone depletes tocopherols and tocotrienols topically applied to murine skin, FEBS Lett 401:167–170.PubMedCrossRefGoogle Scholar
  98. Thomas, J. A., Darby, T. D., Wallin, R. F., Garvin, P. J., and Martis, L., 1978, A review of the biological effects of di-(2-ethylhexyl) phthalate, Toxicol. Appl. Pharmacol. 45:1–27.PubMedCrossRefGoogle Scholar
  99. Torre-Amione, G., Anker, S. D., Bourge, R. C. et al., 2008, Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial, Lancet 371:228–236.PubMedCrossRefGoogle Scholar
  100. Travagli, V., Zanardi, I., Gabbrielli, A., Paccagnini, E., and Bocci, V., 2009a, Artif. Organs, October 10 PMID 19817737.Google Scholar
  101. Travagli, V., Zanardi, I., Bernini, P. et al., 2010, Effects of ozone blood treatment on the metabolite profile of human blood, Intern. J. Toxicol. in press.Google Scholar
  102. Valacchi, G., and Bocci, V., 1999, Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets, Mediators Inflamm. 8:205–209.PubMedCrossRefGoogle Scholar
  103. Valacchi, G., Pagnin, E., Okamoto, T., Corbacho, A. M., Olano, E., Davis, P. A., van der Vliet, A., Packer, L., and Cross, C. E., 2003, Induction of stress proteins and MMP-9 by 0.8 ppm of ozone in murine skin, Biochem. Biophys. Res. Commun. 305:741–746.PubMedCrossRefGoogle Scholar
  104. Valacchi, G., van der Vliet, A., Schock, B. C., Okamoto, T., Obermuller-Jevic, U., Cross, C. E., and Packer, L., 2002, Ozone exposure activates oxidative stress responses in murine skin, Toxicology 179:163–170.PubMedCrossRefGoogle Scholar
  105. Valacchi, G., Weber, S. U., Luu, C., Cross, C. E., and Packer, L., 2000, Ozone potentiates vitamin E depletion by ultraviolet radiation in the murine stratum corneum, FEBS Lett. 466: 165–168.PubMedCrossRefGoogle Scholar
  106. Valeri, C. R., Contreas, T. J., Feingold, H., Shebley, R. H., and Jaeger, R. J., 1973, Accumulation of di-2-ethylhexyl phthalate (DEHP) in whole blood, platelet concentrates and platelet-poor plasma. I: effect of DEHP on platelet survival and function, Environ. Health Perspect. 3: 103–118.PubMedCrossRefGoogle Scholar
  107. van Parijs, L., and Abbas, A. K., 1998, Homeostasis and self-tolerance in the immune system: turning lymphocytes off, Science 280:243–248.PubMedCrossRefGoogle Scholar
  108. Verrax, J., and Calderon, P. B., 2009, Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects, Free Radic. Biol. Med. 47:32–40.PubMedCrossRefGoogle Scholar
  109. Videm, V., Mollnes, T. E., Bergh, K., Fosse, E., Mohr, B., Hagve, T. A., Aasen, A. O., and Svennevig, J. L., 1999, Heparin-coated cardiopulmonary bypass equipment. II. Mechanisms for reduced complement activation in vivo, J. Thorac. Cardiovasc. Surg. 117:803–809.PubMedCrossRefGoogle Scholar
  110. Viebahn-Hänsler, R., 1999a, The use of ozone in medicine, ODREI Publishers, Iffezheim, pp. 1–148.Google Scholar
  111. Viebahn-Hänsler, R., 1999b, Einfluss auf den erythrozytenstoffwechsel, in Ozon-Handbuch. Grundlagen. Prävention. Therapie (E. G. Beck, and R. Viebahn-Hänsler, Eds.), Ecomed, Landsberg, pp. 1–15.Google Scholar
  112. Warkentin, T. E., 2003, Heparin-induced thrombocytopenia: pathogenesis and management, Br. J. Haematol. 121:535–555.PubMedCrossRefGoogle Scholar
  113. Webster, G. J., Hallett, R., Whalley, S. A., Meltzer, M., Balogun, K., Brown, D., Farrington, C. P., Sharma, S., Hamilton, G., Farrow, S. C., Ramsay, M. E., Teo, C. G., and Dusheiko, G. M., 2000, Molecular epidemiology of a large outbreak of hepatitis B linked to autohaemotherapy, Lancet 356:379–384.PubMedCrossRefGoogle Scholar
  114. Wehrli, F., and Steinbart, H., 1954, Erfahrungen mit der Haematogenen Oxydations – Therapie (HOT), Ars. Medici. 10:44–51.Google Scholar
  115. Wenzel, R. P., and Edmond, M. B., 1999, The evolving technology of venous access, N. Engl. J. Med. 340:48–50.PubMedCrossRefGoogle Scholar
  116. Werkmeister, H., 1995, Dekubitalgeschwüre und die Behandlung mit der Ozon-Unterdruckbegasung, in Ozon-Handbuch. Grundlagen. Prävention. Therapie (E. G. Beck, and R. Viebahn-Hänsler, Eds.), Ecomed, Landsberg, p. V-7.1 1–V-7.1 22.Google Scholar
  117. Whysner, J., Conaway, C. C., Verna, L., and Williams, G. M., 1996, Vinyl chloride mechanistic data and risk assessment: DNA reactivity and cross-species quantitative risk extrapolation, Pharmacol. Ther. 71:7–28.PubMedCrossRefGoogle Scholar
  118. Williamson, L. M., 2000, Leucocyte depletion of the blood supply – how will patients benefit? Br. J. Haematol. 110:256–272.PubMedCrossRefGoogle Scholar
  119. Witko-Sarsat, V., Friedlander, M., Nguyen, K. T., Capeillere-Blandin, C., Nguyen, A. T., Canteloup, S., Dayer, J. M., Jungers, P., Drueke, T., and Descamps-Latscha, B., 1998, Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure, J. Immunol. 161:2524–2532.PubMedGoogle Scholar
  120. Shiozawa, A., 2000, Characterization of reactive oxygen species generated from the mixture of NaClO and H2O2 used as root canal irrigants. J. Endod. 26:11–15.PubMedCrossRefGoogle Scholar
  121. Bocci, V., 1999a, Biological and clinical effects of ozone. Has ozonetherapy a future in medicine? Br. J. Biomed. Sci. 56:270–279.PubMedGoogle Scholar
  122. Bocci, V., 1999b, Ozonetherapy as a complementary medical approach. Where are we and where do we need to go? in Proceedings of the International Ozone Symposium, 21 and 22 October 1999, Basel, Switzerland (IOA – EA3G, Ed.), Bauer Druck AG, Basel, pp. 353–374.Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Department of PhysiologyUniversity of SienaSienaItaly

Personalised recommendations